CT And MRI Contrast Agents Market 2030: From 6.2 to 9.8 Billion in Imaging Power
The global CT and MRI contrast agents market was valued at approximately USD 6.22 billion in 2024 and is forecast to increase steadily through the coming years, reaching an estimated USD 9.77 billion by 2030 with a compound annual growth rate (CAGR) of 7.81% from 2025 to 2030. This growth reflects the increasing reliance on advanced diagnostic imaging for early detection and management of a wide range of health conditions, including neurological, cardiovascular, and oncological disorders. Contrast agents, which enhance the clarity and contrast of CT and MRI images, are indispensable in modern radiology as they significantly improve the accuracy of diagnoses and treatment planning. Increasing prevalence of chronic diseases worldwide, such as heart disease, cancers, and neurological conditions, is a critical driver of market expansion. These conditions often require detailed imaging to assess the extent and progression of disease, and contrast agents play a central role in improving vi...